DR. REDDY'S LABORATORIES-ADR (RDY) Stock Income Statement
NYSE:RDY - New York Stock Exchange, Inc. - US2561352038 - ADR - Currency: USD
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 335.20B | 326.44B | 280.11B | 246.70B | 215.45B | |||
| Minority Interest Expense | -619.00M | -701.00M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 106.06B | 107.83B | 89.40B | 83.05B | 79.97B | |||
| Gross Profit | 229.14B | 218.60B | 190.71B | 163.65B | 135.48B | |||
| Operating Expenses | 159.83B | 148.48B | 126.08B | 110.75B | 100.15B | |||
| Research and Development | N/A | 23.88B | 19.35B | 16.20B | 15.10B | |||
| Selling, General, and Administrative Expenses | 99.34B | 107.56B | 92.03B | 82.05B | 73.40B | |||
| Operating Income | 69.31B | 70.13B | 64.63B | 52.90B | 35.33B | |||
| Interest Income/Expense | -2.90B | 4.94B | 4.14B | 3.21B | 2.81B | |||
| Other Income/Expense | 12.30B | 1.91B | 2.34B | 6.29B | 657.00M | |||
| Non Recurring Items | -1.69B | -1.69B | -3.00M | -699.00M | -9.30B | |||
| Income Before Taxes | 77.02B | 76.80B | 72.01B | 60.48B | 30.61B | |||
| Income Tax | 19.59B | 19.54B | 16.23B | 15.41B | 8.83B | |||
| Net Income | 56.81B | 56.55B | 55.78B | 45.07B | 21.82B | |||
| EBITDA | N/A | 87.16B | 79.33B | 65.40B | 46.98B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 68.22 | 67.88 | 67.00 | 54.25 | 26.27 | |||
| Non GAAP EPS | 68.20 | 67.87 | 66.97 | 54.25 | 28.50 | |||
| Statistics | ||||||||
| Gross Profit Margin | 68.36% | 66.97% | 68.08% | 66.34% | 62.88% | |||
| Profit Margin | 16.95% | 17.32% | 19.91% | 18.27% | 10.13% | |||
| Operating Profit Margin | 20.68% | 21.48% | 23.07% | 21.44% | 16.40% | |||
All data in INR